Loading…

Androprostamines A and B, the new anti-prostate cancer agents produced by Streptomyces sp. MK932-CF8

Androgen receptor (AR) is a validated target in all clinical states of prostate cancer. Androprostamines A and B, the new inhibitors of androgen receptor, were isolated from Streptomyces sp. MK932-CF8. Their structures were determined by the spectroscopic analysis, degradation studies and synthesis....

Full description

Saved in:
Bibliographic Details
Published in:Journal of antibiotics 2015-04, Vol.68 (4), p.279-285
Main Authors: Yamazaki, Yohko, Someno, Tetsuya, Igarashi, Masayuki, Kinoshita, Naoko, Hatano, Masaki, Kawada, Manabu, Momose, Isao, Nomoto, Akio
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Androgen receptor (AR) is a validated target in all clinical states of prostate cancer. Androprostamines A and B, the new inhibitors of androgen receptor, were isolated from Streptomyces sp. MK932-CF8. Their structures were determined by the spectroscopic analysis, degradation studies and synthesis. Androprostamines showed potent inhibitory effect against androgen-dependent growth of human prostate cancer cells without cytotoxicity and repressed the androgen-induced expression of AR-regulated genes.
ISSN:0021-8820
1881-1469
DOI:10.1038/ja.2014.135